Hjem › Prostatakreft › Colorado › Colorado Springs
Kliniske studier for Prostatakreft i Colorado Springs, CO
12 studier for Prostatakreft søker deltakere på steder i og rundt Colorado Springs (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RekruttererFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekruttererFase 2
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RekruttererFase 1/2
- Rocky Mountain Cancer Center, Colorado Springs
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruttererFase 3
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
RekruttererFase 2
- Rocky Mountain Cancer Center, Colorado Springs
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruttererFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- og 2 flere
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekruttererFase 1
- Rocky Mountain Cancer Center, Colorado Springs
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
RekruttererTidlig fase 1
- UCHealth-Southern Colorado, Colorado Springs
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RekruttererFase 2
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruttererFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Colorado Springs
- Ulcerøs kolitt14 studier
- Crohns sykdom13 studier
- Ikke-småcellet lungekreft11 studier
- Lungekreft8 studier
- Brystkreft7 studier
- Astma6 studier
- Tykktarmskreft6 studier
- Kolorektal kreft6 studier
- Endetarmskreft4 studier
- Sykdommer med overdreven søvnighet4 studier
- Inflammatorisk tarmsykdom4 studier
- Plateepitelcancer i hode og hals4 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.